Advertisement
Screener

ENVOY MEDICAL, INC. (COCH) Payments of Financing Costs

1.4 / 5 stars · 11/38 Roast Me

ENVOY MEDICAL, INC. Payments of Financing Costs

ENVOY MEDICAL, INC. (COCH) reported Payments of Financing Costs of $421.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Cash Flow › Financing Activities

us-gaap:PaymentsOfFinancingCosts · last filed 2026-08-10

  • ENVOY MEDICAL, INC. payments of financing costs for the quarter ending 2026-06-30 was $213.00K, a 9.75% decline year-over-year.
  • ENVOY MEDICAL, INC. payments of financing costs for the quarter ending 2026-03-31 was $208.00K, a 10.73% decline year-over-year.
  • ENVOY MEDICAL, INC. payments of financing costs for the quarter ending 2025-12-31 was $191.00K, a 10.33% decline year-over-year.
  • ENVOY MEDICAL, INC. payments of financing costs for the quarter ending 2025-09-30 was $167.00K, a 9.24% decline year-over-year.
  • ENVOY MEDICAL, INC. payments of financing costs for fiscal 2023 was $563.00K.
Period endPayments of Financing Costs 3 monthPayments of Financing Costs 6 monthPayments of Financing Costs 9 monthPayments of Financing Costs 12 month
2026-06-30$213.00K
derived: 10-Q 6 month − POS AM 3 month · filed 2026-08-10
$421.00K
10-Q · filed 2026-08-10
$612.00K
derived: sum of 3 quarters · filed 2026-08-10
$779.00K
derived: sum of 4 quarters · filed 2026-08-10
2026-03-31$208.00K
POS AM · filed 2026-06-12
$399.00K
derived: sum of 2 quarters · filed 2026-06-12
$566.00K
derived: sum of 3 quarters · filed 2026-06-12
$802.00K
derived: sum of 4 quarters · filed 2026-08-10
2025-12-31$191.00K
derived: POS AM 12 month − 10-Q 9 month · filed 2026-06-12
$358.00K
derived: sum of 2 quarters · filed 2026-06-12
$594.00K
derived: sum of 3 quarters · filed 2026-08-10
$827.00K
POS AM · filed 2026-06-12
2025-09-30$167.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
$403.00K
derived: sum of 2 quarters · filed 2026-08-10
$636.00K
10-Q · filed 2025-11-10
$849.00K
derived: sum of 4 quarters · filed 2026-08-10
2025-06-30$236.00K
derived: 10-Q 6 month − POS AM 3 month · filed 2026-08-10
$469.00K
10-Q · filed 2026-08-10
$682.00K
derived: sum of 3 quarters · filed 2026-08-10
$866.00K
derived: sum of 4 quarters · filed 2026-08-10
2025-03-31$233.00K
POS AM · filed 2026-06-12
$446.00K
derived: sum of 2 quarters · filed 2026-06-12
$630.00K
derived: sum of 3 quarters · filed 2026-06-12
$892.00K
derived: sum of 4 quarters · filed 2026-06-12
2024-12-31$213.00K
derived: POS AM 12 month − 10-Q 9 month · filed 2026-06-12
$397.00K
derived: sum of 2 quarters · filed 2026-06-12
$659.00K
derived: sum of 3 quarters · filed 2026-06-12
$916.00K
POS AM · filed 2026-06-12
2024-09-30$184.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
$446.00K
derived: sum of 2 quarters · filed 2025-11-10
$703.00K
10-Q · filed 2025-11-10
2024-06-30$262.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31
$519.00K
10-Q · filed 2025-07-31
2024-03-31$257.00K
10-Q · filed 2025-05-01
2023-12-31$563.00K
10-K · filed 2025-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
ALPHA PRO TECH LTD (APT)$0.052B13.63
MYOMO, INC. (MYO)United States$0.065B-2.85
MILESTONE SCIENTIFIC INC. (MLSS)United States$0.036B-6.85
Safe Pro Group Inc. (SPAI)United States$0.090B
Lifeward Ltd. (LFWD)$0.021B
ENvue Medical, Inc. (FEED)United States$0.011B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
NutriBand Inc. (NTRB)United States$0.109B
Bone Biologics Corp (BBLG)United States$0.001B
Conexeu Sciences Inc. (CNXU)United States$0.111B